Preclinical Drug Metabolism and Pharmacokinetics, and Prediction of Human Pharmacokinetics and Efficacious Dose of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237)

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|7|2|96-104

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.7, Iss.2, 2014-05, pp. : 96-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Pharmacokinetics: An Approach Towards Safer and Efficacious Drugs

By  

Current Drug Metabolism, Vol. 7, Iss. 2, 2006-02 ,pp. : 165-182

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics and drug metabolism in the elderly

By Klotz Ulrich  

Drug Metabolism Reviews, Vol. 41, Iss. 2, 2009-05 ,pp. : 67-76

Informa Healthcare

Access to resources Recommend Favorite

Drug metabolism and pharmacokinetics

By Benedetti Margherita Strolin   Whomsley Rhys   Poggesi Italo   Cawello Willi   Mathy François-Xavier   Delporte Marie-Laure   Papeleu Peggy   Watelet Jean-Baptiste  

Drug Metabolism Reviews, Vol. 41, Iss. 3, 2009-08 ,pp. : 344-390

Informa Healthcare

Access to resources Recommend Favorite

Metabolism, Excretion and Pharmacokinetics of MLN3897, a CCR1 Antagonist, in Humans

By  

Drug Metabolism Letters, Vol. 10, Iss. 1, 2016-03 ,pp. : 22-37

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Metabolism and Pharmacokinetics of SB1317 (TG02), a Potent CDK/JAK2/FLT3 Inhibitor

By  

Drug Metabolism Letters, Vol. 6, Iss. 1, 2012-01 ,pp. : 33-42

Bentham Science Publishers

Access to resources Recommend Favorite